Who Paid My Doc
Makena
Drug Reduction Of Risk For Preterm Birth
NDC 64011-243-01
General payments
$864,027
Research payments
$1,224,995
Through program year 2023, $864,027 in general payments and $1,224,995 in research payments were reported against Makena (Reduction Of Risk For Preterm Birth).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $11,046 | 11 |
| 2022 | General | $226,798 | 41 |
| 2022 | Research | $49,036 | 1 |
| 2021 | General | $10,675 | 220 |
| 2021 | Research | $62,617 | 4 |
| 2020 | General | $117,004 | 2,005 |
| 2019 | General | $498,504 | 8,748 |
| 2019 | Research | $1,113,342 | 6 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
11,025 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.